FRM
AMRI

Fox Run Management’s Albany Molecular Research Inc AMRI Stock Holding History

Fox Run Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,900
Closed -$256K – 629
2015
Q4 		$256K Buy
+12,900
New +$245K 0.2% 224

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fox Run Management's AMRI Position: Q1 2016 in Review

Fox Run Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 12,900 shares — an estimated $256K sold.

Fox Run Management first reported a position in AMRI in Q4 2015 and held it in 1 quarter. The position peaked at $256K in Q4 2015. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • Fox Run Management reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • Fox Run Management sold 12,900 Albany Molecular Research Inc shares in Q1 2016, an estimated $256K.
  • Fox Run Management first reported a position in Albany Molecular Research Inc in Q4 2015 and held it in 1 quarter.
  • Fox Run Management's Albany Molecular Research Inc position peaked at $256K in Q4 2015.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.